Intel Corp (INTC)

[mmoy]

I can understand his frustration with the lack of useful
treatment for this problem and how slow research development
can be. I'm more familiar with the three big psychiatric
problems of depression, schizophrenia and bipolar and these
have been thought to be the opposite of Parkinsons in that
they produce an excess of neurotransmitters. The treatments
can include medications that inhibit the neurotransmitters
which I guess is why you have Parkinsons-like symptoms.

The thing about those other three problems is that they affect
much higher percentages of the population and onset is much
earlier in life meaning that economic impacts are much, much
higher. And these three receive a decent amount of attention
by the research community and improvements and brain discoveries seems to be fairly steady.

I think that the biomedical research community and the drug
companies do incredible work. But they clearly do work on
some things much more than others.